Vaccine
Development of duck hepatitis A virus type 1 attenuated vaccine E23-SP80 and its protective efficacy evaluation against DHAV-1 infection in ducks.
Jiajia Li, Phoo Eikari Kyaw, Chanjuan Tan, Kairui Wen, Jiabin Zhang, Yichen Tian, Dengfei Feng, Wenjian Liu, Shuhui Liu, Suquan Song, Liping Yan
Published: 202610.1016/j.vaccine.2026.128258
Abstract
Duck Hepatitis A Virus type 1 (DHAV-1) is a highly pathogenic virus that causes severe mortality in ducklings and results in substantial economic losses to the global duck industry. Live-attenuated DHAV vaccine remains one of the most effective strat…
Preview only. Read the full abstract at the source